A Anant Labs é a renomada e autêntica fabricante e fornecedora de Dutasteride API na Índia.
A Anant tem expertise em química orgânica sintética e análise farmacêutica e fornece serviços de pesquisa personalizados com custo acessível e precisão para a indústria.
Sinônimos
(4aR,4bS,6aS,7S,9aS,9bS,11aR)-N-[2,5-Bis(trifluoromethyl)phenyl]-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahydro-4a,6a-dimethyl-2-oxo-1H-Indeno[5,4-f]quinoline-7-carboxamideDutasteride164656-23-9AvodartAvolveGG-745DuastrideGI-198745GI 198745GG 745Dutasterida(1S,3aS,3bS,5aR,9aR,9bS,11aS)-N-[2,5-bis(trifluoromethyl)phenyl]-9a,11a-dimethyl-7-oxo-1,2,3,3a,3b,4,5,5a,6,9b,10,11-dodecahydroindeno[5,4-f]quinoline-1-carboxamideO0J6XJN02INSC-740477DTXSID8046452(5alpha,17beta)-N-(2,5-Bis(trifluoromethyl)phenyl)-3-oxo-4-azaandrost-1-ene-17-carboxamidealpha,alpha,alpha,alpha',alpha',alpha'-Hexafluoro-3-oxo-4-aza-5alpha-androst-1-ene-17beta-carboxy-2',5'-xylidideNSC-759880DTXCID6026452CHEBI:521033JALYN COMPONENT DUTASTERIDEN-[2,5-bis(trifluoromethyl)phenyl]-3-oxo-4-aza-5alpha-androst-1-ene-17beta-carboxamide(1S,2R,7R,10S,11S,14S,15S)-N-[2,5-bis(trifluoromethyl)phenyl]-2,15-dimethyl-5-oxo-6-azatetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-3-ene-14-carboxamideGG745dutasteridumN-(2,5-bis(trifluoromethyl)phenyl)-3-oxo-4-aza-5alpha-androst-1-ene-17beta-carboxamide(1S,2R,7R,10S,11S,14S,15S)-N-(2,5-bis(trifluoromethyl)phenyl)-2,15-dimethyl-5-oxo-6-azatetracyclo(8.7.0.0^(2,7).0^(11,15))heptadec-3-ene-14-carboxamide(1S,3aS,3bS,5aR,9aR,9bS,11aS)-N-(2,5-bis(trifluoromethyl)phenyl)-9a,11a-dimethyl-7-oxo-1,2,3,3a,3b,4,5,5a,6,9b,10,11-dodecahydroindeno(5,4-f)quinoline-1-carboxamide(5alpha,17beta)-N-[2,5-Bis(trifluoromethyl)phenyl]-3-oxo-4-azaandrost-1-ene-17-carboxamide745, GGRefChem:57229G04CB0217beta-N-(2,5-bis(trifluoromethyl))phenyl-carbamoyl-4-aza-5alpha-androst-1-en-3-oneAvolve,(5alpha,17beta)-N-(2,5-Bis(trifluoromethyl)phenyl)-3-oxo-4-azaandrost-1-ene-17-carboxamideDuagenC27H30F6N2O2MFCD009378691H-Indeno[5,4-f]quinoline-7-carboxamide, N-[2,5-bis(trifluoromethyl)phenyl]-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahydro-4a,6a-dimethyl-2-oxo-, (4aR,4bS,6aS,7S,9aS,9bS,11aR)-(4aR,4bS,6aS,7S,9aS,9bS,11aR)-N-(2,5-Bis(trifluoromethyl)phenyl)-4a,6a-dimethyl-2-oxo-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahydro-1H-indeno[5,4-f]quinoline-7-carboxamideCHEMBL1200969(1S,3aS,3bS,5aR,9aR,11aS)-N-[2,5-bis(trifluoromethyl)phenyl]-9a,11a-dimethyl-7-oxo-1,2,3,3a,3b,4,5,5a,6,9b,10,11-dodecahydroindeno[5,4-f]quinoline-1-carboxamideDutasteride [USAN](5alpha,17beta)-N-[2,5-Bis(trifluoromethyl)phenyl]-3-oxo-4- Aza -androst-1-ene-17-carboxamideAvodart (TN)UNII-O0J6XJN02IDutasteridAvidartDuprostGI198745Dutasteride [USAN:INN:BAN]Avidart;Avodart;Dutagen;Dutasteride CRSAvolve;Duagen;Dutas;NCGC00164571-01(4aR,4bS,6aS,7S,9aS,9bS,11aR)-N-[2,5-Bis(trifluoromethyl)phenyl]-4a,6a-dimethyl-2-oxo-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahydro-1H-indeno[5,4-f]quinoline-7-carboxamide1H-Indeno(5,4-f)quinoline-7-carboxamide, N-(2,5-bis(trifluoromethyl)phenyl)-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahydro-4a,6a-dimethyl-2-oxo-, (4aR,4bS,6aS,7S,9aS,9bS,11aR)-GI-198745XDutasteride (Standard)DUTASTERIDE [MI]DUTASTERIDE [INN]DUTASTERIDE [JAN]DUTASTERIDE [VANDF]SCHEMBL5903DUTASTERIDE [MART.]DUTASTERIDE [USP-RS]DUTASTERIDE [WHO-DD]Dutasteride (JAN/USP/INN)GTPL7457orb1308434Dutasteride - Bio-X trade markSCHEMBL29454739Dutasteride, >=98% (HPLC)DUTASTERIDE [ORANGE BOOK]DUTASTERIDE [EP MONOGRAPH]GLXC-06659DUTASTERIDE [USP MONOGRAPH]EX-A1952MSK15349Tox21_112199BDBM50340481EBC-11281HY-13613RNSC740477s1202AKOS015920136AKOS015924431Dutasteride for system suitability CRSMSK15349-100ACCG-269904CS-1542DB01126FD22629GS-3565MSK15349-1000ANSC 740477NSC 759880(4aR,4bS,6aS,7S,9aS,9bS,11aR)-N-[2,5-bis(trifluoromethyl)phenyl]-4a,6a-dimethyl-2-oxo-1H,2H,4aH,4bH,5H,6H,6aH,7H,8H,9H,9aH,9bH,10H,11H,11aH-indeno[5,4-f]quinoline-7-carboxamideBD164398HY-13613CAS-164656-23-9D5973D03820Dutasteride Solution in Acetonitrile, 100ug/mLEN300-124223AB01274774-01AB01274774_02Dutasteride Solution in Acetonitrile, 1000ug/mLQ424760BRD-K30373883-001-02-8Z1558504346Dutasteride, European Pharmacopoeia (EP) Reference StandardDutasteride, United States Pharmacopeia (USP) Reference StandardDutasteride for system suitability, European Pharmacopoeia (EP) Reference Standard(5.ALPHA.,17.BETA.)-N-(2,5-BIS(TRIFLUOROMETHYL)PHENYL)-3-OXO-4-AZAANDROST-1-ENE-17-CARBOXAMIDE(5.alpha.,5 bis(trifluoromethyl)phenyl}-3-oxo-4-azaandrost-1-ene-17-carboxamide;dutasteride;Avodart;(5|_,17|_)-N-[2,5-Bis(trifluoromethyl)phenyl]-3-oxo-4- Aza -androst-1-ene-17-carboxamide(5alpha,17beta)-N-{2,5-bis(trifluoromethyl)-phenyl}-3-oxo-4-azaandrost-1-ene-17-carboxamide.ALPHA.,.ALPHA.,.ALPHA.,.ALPHA.',.ALPHA.',.ALPHA.'-HEXAFLUORO-3-OXO-4-AZA-5.ALPHA.-ANDROST-1-ENE-17.BETA.-CARBOXY-2',5'-XYLIDIDE
